Pathstone Family Office LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Pathstone Family Office LLC
CRD #151736
SEC #801-70776
CIK #0001511137
AUM 110.30 B (2026-03-31)
Employees 704 (52% Investors, 0% Brokers)
Fees
Minimum
Phone201-944-7284
Address10 Sterling Blvd
Englewood, NJ 07631
Source [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn] [Facebook]
Total AUM ($B)
1209672482402009201520212027
Sector Form 13F Holdings Value ($B)
Apple Inc 0.7
Microsoft Corp 0.6
Nvidia Corp 0.6
Amazon Com Inc 0.3
Alphabet Inc 0.3
Coca Cola Co 0.2
Alphabet Inc 0.2
Tesla Motors Inc 0.2
Broadcom Inc 0.2
Facebook Inc 0.2
View All
Holdings by Sector ($B)
200160120804002011201620212027
Type Form D Funds Date Sold AUM
PE HCP Full Consequence Investing Fund IV LP [2026-03-31] 1.3 M
Filed 2025-03-20 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
PE Pathstone AI Coinvest 2025 LP [2026-03-31] 141.8 M 142.2 M
Filed 2025-08-26 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose
PE Pathstone Early Stage Venture Fund LP - Series 5 [2026-03-31]
Filed 2025-07-24 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose
PE Pathstone Private Innovations 2025 LP [2026-03-31] 67.2 M
Filed 2025-05-28 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $1 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF VLP060 2026-03-31 102.2 M
HF VLP059 2025-03-31 115.6 M
PE HCP Private Equity Fund XII-A LP [2025-03-19] 25.0 M 4.1 M
Filed 2025-03-26 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose
PE HCP Private Equity Fund XII LP [2025-03-19] 165.8 M 29.1 M
Filed 2025-03-26 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose
VC ESP Investors LLC 2024-03-29 5.1 M
HF VLP058 2024-03-29 146.3 M
View All
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 145 0.1
(b) Individuals (high net worth individuals) 1,834 91.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 165 10.7
(g) Pension and profit sharing plans 5 0.3
(h) Charitable organizations 72 6.3
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 23 1.9
(n) Other 0 0.0
Total 27,165 110.3
By Discretionary
Discretionary 17,133 65.6
Non-Discretionary 10,032 44.7
Total 27,165 110.3
By Non-United States Persons
Non-United States Persons 1.1
United States Persons 109.2
Total 27,165 110.3
Form D Directors Role # Filings # Firms 2011 - 2026
Michael Sherman Director, Executive Officer 74 8
Charles Keates Executive Officer 19 5
Dennis Ersin Executive Officer 9 5
Kathryn Hall Director, Executive Officer 55 4
Hull McKinnon Executive Officer 50 4
Michael Hughes Executive Officer 34 4
Michael Stolper Executive Officer 20 4
Eric Kramer Director, Executive Officer 75 3
Hall Capital Partners LLC Director, Executive Officer 45 3
Mark McKee Director 36 3
View All
EDGAR Form CIK 2011 - 2026
13F-HR [0001511137]
13F-NT [0001511137]
SC 13G [0001511137]
Form 13D/13G Filer Form 13D/13G Subject Filed
Pathstone Family Office LLC Biopower Operations Corp [2025-08-15]
Pathstone Family Office LLC Nkgen Biotech Inc [2025-02-28]
Pathstone Family Office LLC Cognition Therapeutics Inc [2025-02-04]
Pathstone Family Office LLC Cognition Therapeutics Inc [2024-01-19]
Firm Profile (Form ADV)
Discretionary AUM$0.7B
ServesInstitutional, Retail, Research
Fund TypesHedge Fund, Private Equity, Real Estate
Comparable Firms State AUM
SEI Investments Management Corp
PA 216.43 B
Stifel Nicolaus & Company Incorporated
MO 197.53 B
Focus Partners Wealth LLC
MO 181.86 B
Goldman Sachs & Co LLC
NY 133.64 B
Cresset Asset Management LLC
IL 78.94 B
Wells Fargo Investment Institute Inc
NC 43.00 B
Sequoia Financial Advisors LLC
OH 32.24 B
Vivaldi Capital Management LP
IL 5,641.1 M
Three Bell Capital LLC
TX 5,051.1 M
Avidian Wealth Enterprises LLC
TX 4,764.2 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com